Lombard Life Sciences manages the Western Life Sciences Venture Fund LP, a $45 million venture capital fund that aims to create, acquire, and develop early and later stage human bio/medical technology companies. The fund's mission is to provide intellectual and financial support to emerging life science companies, helping them reach a stage where they can secure significant public or private financing or strategic partnerships. By doing so, these companies can contribute to improving the quality of healthcare while reducing its costs. Ultimately, the fund aims to deliver substantial returns to its investors.